Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B

  • Technology appraisal guidance
  • TA96
  • Published: 
Download guidance (PDF)

6 Implications for the NHS

6.1 Since the final appraisal determination was issued, NICE has carried out more detailed costing analysis to support implementation of the guidance. The following costing tools are available from the NICE website.

  • A national costing report, which estimates the overall resource impact associated with implementation.

  • A local costing template: a simple spreadsheet that can be used to estimate the local cost of implementation.